Transforming neuro-restoration across the continuum of care, MindMaze Healthcare uses cutting edge neuroscience to maximise the recovery potential of patients with debilitating neurological diseases, and mitigate the impact of ageing on cognition and movement.

A hub of advanced neuroscience, deep tech and innovative engineering, MindMaze Labs’ mission is to improve every aspect of life. By decoding the brain and harnessing its power, their neuro-technology aims to be the foundation upon which the next generation of human-machine interfaces is built.

Presence & Progress:

The first Swiss unicorn, valued at an estimated $1.5Bn. Now with a presence in 19 countries and 60 issued or pending patents. 

Partnerships:  

Partnerships established with John Hopkins University, Formula 1 and the University of Auckland.

Investment:

Existing investors include Concord Health Partners, AlbaCore Capital Group, Hinduja Group, Hambro Perks and Leonardo DiCaprio.

Hailing from over 20 countries, the multidisciplinary team spans restorative neuroscience, neurotechnology, brain-computer interface, robotics and game design.

With experience ranging across medical corporations (KB Medical, Sensimed), academic institutions (Johns Hopkins, Cambridge) & commercial industries (UBS Investment Bank, CitiGroup, Philips Electronics). 

MindMaze was recently recognised by Deloitte as one of Switzerland's Best Managed Companies. The list recognises Swiss companies which are operating at the highest levels of business excellence. 

The first innovation from their ongoing partnerships in Formula 1 and DTM, MindDrive is a biosensing net that captures drivers’ and pit crews’ key neural signatures as the race unfolds.

A first-of-its-kind mobile neurorehabilitation therapy system, MindMotion™ GO brings gamified neurorehabilitation developed by neuroscientists for specialists.

This Secondary Share Sale offer is made to investors without the involvement of MindMaze in preparing the offer materials. Accordingly, all of the information contained in this offer is publicly available and sourced either from MindMaze’s website, PitchBook or from online publications. The sources that have been used to build the above information are listed below. Seedrs has not verified any of the information set out in this offer, and all investors must complete their own due diligence prior to making an investment decision.

https://mindmaze.com/about/ 

https://mindmaze.com/team/

https://www.fiercebiotech.com/medtech/mindmaze-chases-down-another-100m-funding-plus-aha-partnership 

https://siliconcanals.com/crowdfunding/mindmaze-raises-92-37m/

https://www2.deloitte.com/ch/en/pages/private-market/articles/meet-our-best-managed-companies.html 

https://www.cbinsights.com/company/mindmaze 

https://www.crunchbase.com/organization/mindmaze/company_financials